- Home
- Publications
- Publication Search
- Publication Details
Title
Multiple sclerosis
Authors
Keywords
-
Journal
Nature Reviews Disease Primers
Volume 4, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-08
DOI
10.1038/s41572-018-0041-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis
- (2018) Sabina Luchetti et al. ACTA NEUROPATHOLOGICA
- Inflammatory intrathecal profiles and cortical damage in multiple sclerosis
- (2018) Roberta Magliozzi et al. ANNALS OF NEUROLOGY
- Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies
- (2018) Pietro Maggi et al. ANNALS OF NEUROLOGY
- T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention
- (2018) Jamie van Langelaar et al. BRAIN
- The value of oligoclonal bands in the multiple sclerosis diagnostic criteria
- (2018) Georgina Arrambide et al. BRAIN
- The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells
- (2018) Joana Machado-Santos et al. BRAIN
- Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome
- (2018) Clara Matute-Blanch et al. BRAIN
- The Evidence for Dietary Interventions and Nutritional Supplements as Treatment Options in Multiple Sclerosis: a Review
- (2018) Leah J. Mische et al. Current Treatment Options in Neurology
- Can Optical Coherence Tomography Be Used to Guide Treatment Decisions in Adult or Pediatric Multiple Sclerosis?
- (2018) Jeffrey Lambe et al. Current Treatment Options in Neurology
- MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
- (2018) S. Jarius et al. Journal of Neuroinflammation
- Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis
- (2018) Hanane Touil et al. Journal of Neuroinflammation
- Randomised controlled trial of a self-guided online fatigue intervention in multiple sclerosis
- (2018) Jana Pöttgen et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
- (2018) Raju Kapoor et al. LANCET NEUROLOGY
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study
- (2018) Massimo Filippi et al. LANCET NEUROLOGY
- Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
- (2018) Nelly Siller et al. Multiple Sclerosis Journal
- Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations
- (2018) Nicola De Stefano et al. Multiple Sclerosis Journal
- ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
- (2018) Xavier Montalban et al. Multiple Sclerosis Journal
- Reassessing B cell contributions in multiple sclerosis
- (2018) Rui Li et al. NATURE IMMUNOLOGY
- The current role of MRI in differentiating multiple sclerosis from its imaging mimics
- (2018) Ruth Geraldes et al. Nature Reviews Neurology
- Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis
- (2018) Alexander Rae-Grant et al. NEUROLOGY
- Multiple Sclerosis: Mechanisms and Immunotherapy
- (2018) Clare Baecher-Allan et al. NEURON
- IL-1β enables CNS access to CCR2himonocytes and the generation of pathogenic cells through GM-CSF released by CNS endothelial cells
- (2018) Alexandre Paré et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- People with multiple sclerosis report significantly worse symptoms and health related quality of life than the US general population as measured by PROMIS and NeuroQoL outcome measures
- (2018) Dagmar Amtmann et al. Disability and Health Journal
- A Review of the Current Evidence on Gadolinium Deposition in the Brain
- (2018) Richard Pullicino et al. Clinical Neuroradiology
- Effector T Cells in Multiple Sclerosis
- (2018) Belinda J. Kaskow et al. Cold Spring Harbor Perspectives in Medicine
- Regulatory T Cells: From Discovery to Autoimmunity
- (2018) Alexandra Kitz et al. Cold Spring Harbor Perspectives in Medicine
- Multiple Sclerosis Pathology
- (2018) Hans Lassmann Cold Spring Harbor Perspectives in Medicine
- Association of Retinal Ganglion Cell Layer Thickness With Future Disease Activity in Patients With Clinically Isolated Syndrome
- (2018) Hanna G. Zimmermann et al. JAMA Neurology
- Comparative Effectiveness of Rituximab and Other Initial Treatment Choices for Multiple Sclerosis
- (2018) Mathias Granqvist et al. JAMA Neurology
- Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
- (2018) Nelly Siller et al. Multiple Sclerosis Journal
- Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations
- (2018) Nicola De Stefano et al. Multiple Sclerosis Journal
- ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
- (2018) Xavier Montalban et al. Multiple Sclerosis Journal
- Worldwide prevalence of familial multiple sclerosis: A systematic review and meta-analysis
- (2018) Mohammad Hossein Harirchian et al. Multiple Sclerosis and Related Disorders
- Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis
- (2018) Peter J. Darlington et al. Frontiers in Immunology
- Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis
- (2018) Ivan Jelcic et al. CELL
- MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder
- (2018) Ram Narayan et al. Multiple Sclerosis and Related Disorders
- Multiple sclerosis: Frequency, cost, and economic burden in the United States
- (2017) Alex Y. Chen et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Antibody-Independent Function of Human B Cells Contributes to Antifungal T Cell Responses
- (2017) Rui Li et al. JOURNAL OF IMMUNOLOGY
- B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro
- (2017) Robert P. Lisak et al. JOURNAL OF NEUROIMMUNOLOGY
- Excess mortality among patients with multiple sclerosis in Denmark has dropped significantly over the past six decades: a population based study
- (2017) Nils Koch-Henriksen et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study
- (2017) Hanne Marie Bøe Lunde et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cortical Remyelination Is Heterogeneous in Multiple Sclerosis
- (2017) Eva M.M. Strijbis et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- NEDA treatment target? No evident disease activity as an actionable outcome in practice
- (2017) Natalie E. Parks et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Evolving concepts in the treatment of relapsing multiple sclerosis
- (2017) Giancarlo Comi et al. LANCET
- Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial
- (2017) Ari J Green et al. LANCET
- Diagnosis of multiple sclerosis: progress and challenges
- (2017) Wallace J Brownlee et al. LANCET
- Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
- (2017) Axel Petzold et al. LANCET NEUROLOGY
- Exercise in patients with multiple sclerosis
- (2017) Robert W Motl et al. LANCET NEUROLOGY
- Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor
- (2017) Georgina Arrambide et al. Multiple Sclerosis Journal
- Diagnostic performance of central vein sign for multiple sclerosis with a simplified three-lesion algorithm
- (2017) Andrew J Solomon et al. Multiple Sclerosis Journal
- Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop
- (2017) Maria Pia Amato et al. Multiple Sclerosis Journal
- Targets of therapy in progressive MS
- (2017) Hans Lassmann Multiple Sclerosis Journal
- New insights into the burden and costs of multiple sclerosis in Europe
- (2017) Gisela Kobelt et al. Multiple Sclerosis Journal
- Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
- (2017) Fredrik Piehl et al. Multiple Sclerosis Journal
- “No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis
- (2017) Gavin Giovannoni et al. Multiple Sclerosis Journal
- Comorbidity in multiple sclerosis: implications for patient care
- (2017) Ruth Ann Marrie Nature Reviews Neurology
- Treatment decisions in multiple sclerosis — insights from real-world observational studies
- (2017) Maria Trojano et al. Nature Reviews Neurology
- Older Age at Multiple Sclerosis Onset Is an Independent Factor of Poor Prognosis: A Population-Based Cohort Study
- (2017) Francis Guillemin et al. NEUROEPIDEMIOLOGY
- Brain mapping in multiple sclerosis: Lessons learned about the human brain
- (2017) Massimo Filippi et al. NEUROIMAGE
- Alemtuzumab CARE-MS I 5-year follow-up
- (2017) Eva Havrdova et al. NEUROLOGY
- Fast multiple sclerosis progression in North Africans
- (2017) Youssef Sidhom et al. NEUROLOGY
- Alemtuzumab CARE-MS II 5-year follow-up
- (2017) Alasdair J. Coles et al. NEUROLOGY
- Autologous hematopoietic stem cell transplantation in multiple sclerosis
- (2017) Maria Pia Sormani et al. NEUROLOGY
- Mortality trends for multiple sclerosis patients in Sweden from 1968 to 2012
- (2017) Sarah Burkill et al. NEUROLOGY
- Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2017) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Genetics of Multiple Sclerosis: From 0 to 200 in 50 Years
- (2017) Sergio E. Baranzini et al. TRENDS IN GENETICS
- Dominant Optic Atrophy and Leber’s Hereditary Optic Neuropathy: Update on Clinical Features and Current Therapeutic Approaches
- (2017) Bo Young Chun et al. Seminars in Pediatric Neurology
- Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
- (2017) Paolo A. Muraro et al. JAMA Neurology
- Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor
- (2017) Georgina Arrambide et al. Multiple Sclerosis Journal
- Diagnostic performance of central vein sign for multiple sclerosis with a simplified three-lesion algorithm
- (2017) Andrew J Solomon et al. Multiple Sclerosis Journal
- Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop
- (2017) Maria Pia Amato et al. Multiple Sclerosis Journal
- Targets of therapy in progressive MS
- (2017) Hans Lassmann Multiple Sclerosis Journal
- New insights into the burden and costs of multiple sclerosis in Europe
- (2017) Gisela Kobelt et al. Multiple Sclerosis Journal
- Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
- (2017) Fredrik Piehl et al. Multiple Sclerosis Journal
- “No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis
- (2017) Gavin Giovannoni et al. Multiple Sclerosis Journal
- Vitamin D and multiple sclerosis: An update
- (2017) Charles Pierrot-Deseilligny et al. Multiple Sclerosis and Related Disorders
- Fatigue and depression in multiple sclerosis: pharmacological and non-pharmacological interventions
- (2016) P. Brenner et al. ACTA NEUROLOGICA SCANDINAVICA
- MRI and neurophysiological measures to predict course, disability and treatment response in multiple sclerosis
- (2016) Letizia Leocani et al. CURRENT OPINION IN NEUROLOGY
- TREATING MULTIPLE SCLEROSIS WITH CLADRIBINE
- (2016) C Alvarez-Gonzalez et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
- (2016) Fred Lublin et al. LANCET
- Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial
- (2016) Rhian Raftopoulos et al. LANCET NEUROLOGY
- MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
- (2016) Massimo Filippi et al. LANCET NEUROLOGY
- Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial
- (2016) Jeffrey A Cohen et al. LANCET NEUROLOGY
- A Multidimensional Computerized Adaptive Short-Form Quality of Life Questionnaire Developed and Validated for Multiple Sclerosis
- (2016) Pierre Michel et al. MEDICINE
- Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study
- (2016) Axel Petzold et al. Multiple Sclerosis Journal
- Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions
- (2016) Niraj Mistry et al. Multiple Sclerosis Journal
- Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome
- (2016) WJ Brownlee et al. Multiple Sclerosis Journal
- Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis
- (2016) Ludwig Kappos et al. Multiple Sclerosis Journal
- Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
- (2016) Tomas Olsson et al. Nature Reviews Neurology
- The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative
- (2016) Pascal Sati et al. Nature Reviews Neurology
- The APOSTEL recommendations for reporting quantitative optical coherence tomography studies
- (2016) Andrés Cruz-Herranz et al. NEUROLOGY
- Recommendations for observational studies of comorbidity in multiple sclerosis
- (2016) Ruth Ann Marrie et al. NEUROLOGY
- The challenge of comorbidity in clinical trials for multiple sclerosis
- (2016) Ruth Ann Marrie et al. NEUROLOGY
- The contemporary spectrum of multiple sclerosis misdiagnosis
- (2016) Andrew J. Solomon et al. NEUROLOGY
- Brain MRI atrophy quantification in MS
- (2016) Maria A. Rocca et al. NEUROLOGY
- Neurofilament light chain level is a weak risk factor for the development of MS
- (2016) Georgina Arrambide et al. NEUROLOGY
- Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis
- (2016) Tingting Zhang et al. NEUROLOGY
- Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention—An Update
- (2016) Kassandra Munger et al. SEMINARS IN NEUROLOGY
- Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells
- (2016) Francesca Ronchi et al. Nature Communications
- Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis
- (2016) Ludwig Kappos et al. JAMA Neurology
- Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study
- (2016) Axel Petzold et al. Multiple Sclerosis Journal
- Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions
- (2016) Niraj Mistry et al. Multiple Sclerosis Journal
- Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome
- (2016) WJ Brownlee et al. Multiple Sclerosis Journal
- Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis
- (2016) Ludwig Kappos et al. Multiple Sclerosis Journal
- Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis
- (2016) K.M. Fiest et al. Multiple Sclerosis and Related Disorders
- Brain health: time matters in multiple sclerosis
- (2016) Gavin Giovannoni et al. Multiple Sclerosis and Related Disorders
- The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue
- (2016) Christian Veauthier et al. EPMA Journal
- Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society
- (2016) DE Moulin et al. Pain Research & Management
- Melanoma cell adhesion molecule-positive CD8 T lymphocytes mediate central nervous system inflammation
- (2015) Catherine Larochelle et al. ANNALS OF NEUROLOGY
- Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque
- (2015) Josa M. Frischer et al. ANNALS OF NEUROLOGY
- Dynamics of retinal injury after acute optic neuritis
- (2015) Iñigo Gabilondo et al. ANNALS OF NEUROLOGY
- Reconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosis
- (2015) Tanja Jürgens et al. BRAIN
- Defining high, medium and low impact prognostic factors for developing multiple sclerosis
- (2015) Mar Tintore et al. BRAIN
- Two Multiple Sclerosis Quality-of-Life Measures: Comparison in a National Sample
- (2015) Fraser Moore et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-β Therapy
- (2015) Javad Rasouli et al. JOURNAL OF IMMUNOLOGY
- Circulating Follicular Regulatory T Cells Are Defective in Multiple Sclerosis
- (2015) Tessa Dhaeze et al. JOURNAL OF IMMUNOLOGY
- ATON: Results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis
- (2015) Robert C. Sergott et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis
- (2015) Maria A Rocca et al. LANCET NEUROLOGY
- Pathological mechanisms in progressive multiple sclerosis
- (2015) Don H Mahad et al. LANCET NEUROLOGY
- Antibodies to the inward rectifying potassium channel 4.1 in multiple sclerosis: different methodologies—conflicting results?
- (2015) Bernhard Hemmer Multiple Sclerosis Journal
- Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
- (2015) J Kuhle et al. Multiple Sclerosis Journal
- No evidence of disease activity in multiple sclerosis: Implications on cognition and brain atrophy
- (2015) Alfredo Damasceno et al. Multiple Sclerosis Journal
- Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort
- (2015) Immy A Ketelslegers et al. Multiple Sclerosis Journal
- Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
- (2015) M Alba Mañé Martínez et al. Multiple Sclerosis Journal
- The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
- (2015) Ruth Ann Marrie et al. Multiple Sclerosis Journal
- Structural and functional features of central nervous system lymphatic vessels
- (2015) Antoine Louveau et al. NATURE
- MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process
- (2015) Àlex Rovira et al. Nature Reviews Neurology
- Body fluid biomarkers for multiple sclerosis—the long road to clinical application
- (2015) Charlotte E. Teunissen et al. Nature Reviews Neurology
- Focal disturbances in the blood–brain barrier are associated with formation of neuroinflammatory lesions
- (2015) Jorge Ivan Alvarez et al. NEUROBIOLOGY OF DISEASE
- Long-term assessment of no evidence of disease activity in relapsing-remitting MS
- (2015) Nicola De Stefano et al. NEUROLOGY
- International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
- (2015) Dean M. Wingerchuk et al. NEUROLOGY
- Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
- (2015) J. Kuhle et al. NEUROLOGY
- Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2015) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy
- (2015) Rui Li et al. Science Translational Medicine
- Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis
- (2015) Yonghao Cao et al. Science Translational Medicine
- Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study
- (2015) Lauren E. Mokry et al. PLOS MEDICINE
- Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort
- (2015) Dalia L. Rotstein et al. JAMA Neurology
- Antibodies to the inward rectifying potassium channel 4.1 in multiple sclerosis: different methodologies—conflicting results?
- (2015) Bernhard Hemmer Multiple Sclerosis Journal
- Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
- (2015) J Kuhle et al. Multiple Sclerosis Journal
- No evidence of disease activity in multiple sclerosis: Implications on cognition and brain atrophy
- (2015) Alfredo Damasceno et al. Multiple Sclerosis Journal
- Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort
- (2015) Immy A Ketelslegers et al. Multiple Sclerosis Journal
- Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
- (2015) M Alba Mañé Martínez et al. Multiple Sclerosis Journal
- The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
- (2015) Ruth Ann Marrie et al. Multiple Sclerosis Journal
- Remyelination Therapy in Multiple Sclerosis
- (2015) Danielle E. Harlow et al. Frontiers in Neurology
- Therapeutic Intervention in Multiple Sclerosis with Alpha B-Crystallin: A Randomized Controlled Phase IIa Trial
- (2015) Johannes M. van Noort et al. PLoS One
- Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy
- (2014) Tatiana Plavina et al. ANNALS OF NEUROLOGY
- Role of the Blood–Brain Barrier in Multiple Sclerosis
- (2014) Genaro Gabriel Ortiz et al. ARCHIVES OF MEDICAL RESEARCH
- Vision and vision-related outcome measures in multiple sclerosis
- (2014) L. J. Balcer et al. BRAIN
- Relapsing and progressive forms of multiple sclerosis
- (2014) Ranjan Dutta et al. CURRENT OPINION IN NEUROLOGY
- Magnetic resonance outcome measures in multiple sclerosis trials
- (2014) Massimo Filippi et al. CURRENT OPINION IN NEUROLOGY
- Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients
- (2014) Arumugam Palanichamy et al. JOURNAL OF IMMUNOLOGY
- A changing treatment landscape for multiple sclerosis: challenges and opportunities
- (2014) F. Piehl JOURNAL OF INTERNAL MEDICINE
- N-Acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosis
- (2014) Alessandro Trentini et al. JOURNAL OF NEUROLOGY
- Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron
- (2014) Lukas Haider et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial
- (2014) Jeremy Chataway et al. LANCET
- Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study
- (2014) Peter A Calabresi et al. LANCET NEUROLOGY
- Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study
- (2014) Adipong Brickshawana et al. LANCET NEUROLOGY
- Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2014) Christian Confavreux et al. LANCET NEUROLOGY
- Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2014) Peter A Calabresi et al. LANCET NEUROLOGY
- Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria
- (2014) S Schippling et al. Multiple Sclerosis Journal
- Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis
- (2014) Divya Narayanan et al. Multiple Sclerosis Journal
- Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study
- (2014) Anat Achiron et al. Multiple Sclerosis Journal
- The investigation of acute optic neuritis: a review and proposed protocol
- (2014) Axel Petzold et al. Nature Reviews Neurology
- Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis
- (2014) A. K. Hedstrom et al. NEUROLOGY
- Epitope spreading as an early pathogenic event in pediatric multiple sclerosis
- (2014) F. J. Quintana et al. NEUROLOGY
- Defining the clinical course of multiple sclerosis: The 2013 revisions
- (2014) F. D. Lublin et al. NEUROLOGY
- Obesity during childhood and adolescence increases susceptibility to multiple sclerosis after accounting for established genetic and environmental risk factors
- (2014) Milena A. Gianfrancesco et al. Obesity Research & Clinical Practice
- Radiologically Isolated Syndrome: 5-Year Risk for an Initial Clinical Event
- (2014) Darin T. Okuda et al. PLoS One
- Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis
- (2014) A. Palanichamy et al. Science Translational Medicine
- B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes
- (2014) J. N. H. Stern et al. Science Translational Medicine
- Urodynamics in the Evaluation of the Patient with Multiple Sclerosis
- (2014) Benjamin E. Dillon et al. UROLOGIC CLINICS OF NORTH AMERICA
- Towards the implementation of ‘no evidence of disease activity’ in multiple sclerosis treatment: the multiple sclerosis decision model
- (2014) Martin Stangel et al. Therapeutic Advances in Neurological Disorders
- miR-155 as a multiple sclerosis-relevant regulator of myeloid cell polarization
- (2013) Craig S. Moore et al. ANNALS OF NEUROLOGY
- Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis
- (2013) Maria Pia Sormani et al. ANNALS OF NEUROLOGY
- Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis
- (2013) Sofia V. Abrahamsson et al. BRAIN
- Cortical imaging in multiple sclerosis
- (2013) Marita Daams et al. CURRENT OPINION IN NEUROLOGY
- A practical approach to diagnosing adult onset leukodystrophies
- (2013) R. M. Ahmed et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude
- (2013) R. Dobson et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials
- (2013) Maria Pia Sormani et al. LANCET NEUROLOGY
- Body fluid biomarkers in multiple sclerosis
- (2013) Manuel Comabella et al. LANCET NEUROLOGY
- Optic neuritis
- (2013) Ahmed T Toosy et al. LANCET NEUROLOGY
- Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes
- (2013) Vittorio Martinelli et al. Multiple Sclerosis Journal
- Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome
- (2013) Timm Oberwahrenbrock et al. Multiple Sclerosis Journal
- Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
- (2013) Ashley H Beecham et al. NATURE GENETICS
- Epstein-Barr virus in oral shedding of children with multiple sclerosis
- (2013) C. Yea et al. NEUROLOGY
- Gray matter damage predicts the accumulation of disability 13 years later in MS
- (2013) M. Filippi et al. NEUROLOGY
- Mortality in patients with multiple sclerosis
- (2013) A. Scalfari et al. NEUROLOGY
- Grey matter damage in multiple sclerosis
- (2013) Roel Klaver et al. Prion
- Sleep disorders in multiple sclerosis and their relationship to fatigue
- (2013) Christian Veauthier et al. SLEEP MEDICINE
- Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis
- (2013) Daniela F. Angelini et al. PLoS Pathogens
- Transdermal Application of Myelin Peptides in Multiple Sclerosis Treatment
- (2013) Agata Walczak et al. JAMA Neurology
- Relationships Between Retinal Axonal and Neuronal Measures and Global Central Nervous System Pathology in Multiple Sclerosis
- (2013) Shiv Saidha et al. JAMA Neurology
- Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis
- (2012) Sung R. Choi et al. BRAIN
- IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis
- (2012) Magdalena Huber et al. JOURNAL OF CLINICAL INVESTIGATION
- B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
- (2012) Tom A. Barr et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro
- (2012) Robert P. Lisak et al. JOURNAL OF NEUROIMMUNOLOGY
- Patients with migraine do not have MRI-visible cortical lesions
- (2012) Martina Absinta et al. JOURNAL OF NEUROLOGY
- Treatment of cognitive impairment in multiple sclerosis: position paper
- (2012) Maria Pia Amato et al. JOURNAL OF NEUROLOGY
- B-Cell Enrichment and Epstein-Barr Virus Infection in Inflammatory Cortical Lesions in Secondary Progressive Multiple Sclerosis
- (2012) Roberta Magliozzi et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- Clinically isolated syndromes
- (2012) David H Miller et al. LANCET NEUROLOGY
- High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women
- (2012) Anna K Hedström et al. Multiple Sclerosis Journal
- Effect of gender on late-onset multiple sclerosis
- (2012) Riley M Bove et al. Multiple Sclerosis Journal
- CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome
- (2012) M Khalil et al. Multiple Sclerosis Journal
- Progressive multiple sclerosis: pathology and pathogenesis
- (2012) Hans Lassmann et al. Nature Reviews Neurology
- Spinal cord lesions in patients with clinically isolated syndrome: A powerful tool in diagnosis and prognosis
- (2012) M. H. Sombekke et al. NEUROLOGY
- No MRI evidence of cortical lesions in neuromyelitis optica
- (2012) M. Calabrese et al. NEUROLOGY
- Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis
- (2012) T. Sinnecker et al. NEUROLOGY
- Postmortem verification of MS cortical lesion detection with 3D DIR
- (2012) A. Seewann et al. NEUROLOGY
- Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis
- (2012) Rajneesh Srivastava et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gestational vitamin D and the risk of multiple sclerosis in offspring
- (2011) Fariba Mirzaei et al. ANNALS OF NEUROLOGY
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis
- (2011) Ajit Singh Dhaunchak et al. ANNALS OF NEUROLOGY
- Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis
- (2011) Anna Karin Hedström et al. BRAIN
- CD161highCD8+T cells bear pathogenetic potential in multiple sclerosis
- (2011) Viviana Annibali et al. BRAIN
- Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
- (2011) Owain W. Howell et al. BRAIN
- A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
- (2011) A. Novotna et al. EUROPEAN JOURNAL OF NEUROLOGY
- Cost of disorders of the brain in Europe 2010
- (2011) Anders Gustavsson et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Epstein-Barr virus and multiple sclerosis: interaction with HLA
- (2011) E Sundqvist et al. GENES AND IMMUNITY
- Role of gender in multiple sclerosis: Clinical effects and potential molecular mechanisms
- (2011) Judith M. Greer et al. JOURNAL OF NEUROIMMUNOLOGY
- Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada
- (2011) E Kingwell et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The effect of gender in clinically isolated syndrome (CIS): a meta-analysis
- (2011) Ruth Dobson et al. Multiple Sclerosis Journal
- Multiple sclerosis and depression
- (2011) Anthony Feinstein Multiple Sclerosis Journal
- Cortical lesions in radiologically isolated syndrome
- (2011) A. Giorgio et al. NEUROLOGY
- Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
- (2011) Paul O'Connor et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence
- (2011) J. I. Alvarez et al. SCIENCE
- Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
- (2010) Martin Gunnarsson et al. ANNALS OF NEUROLOGY
- A phase 3 trial of extended release oral dalfampridine in multiple sclerosis
- (2010) Andrew D. Goodman et al. ANNALS OF NEUROLOGY
- A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis
- (2010) Roberta Magliozzi et al. ANNALS OF NEUROLOGY
- Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients
- (2010) Ranjan Dutta et al. ANNALS OF NEUROLOGY
- Changes in B- and T-Lymphocyte and Chemokine Levels With Rituximab Treatment in Multiple Sclerosis
- (2010) Laura Piccio et al. ARCHIVES OF NEUROLOGY
- Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration
- (2010) A. J. Green et al. BRAIN
- The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability
- (2010) Antonio Scalfari et al. BRAIN
- Interpreting scores on multiple sclerosis-specific patient reported outcome measures (the PRIMUS and U-FIS)
- (2010) James Twiss et al. Health and Quality of Life Outcomes
- The changing demographic pattern of multiple sclerosis epidemiology
- (2010) Nils Koch-Henriksen et al. LANCET NEUROLOGY
- Emerging effects of comorbidities on multiple sclerosis
- (2010) Ruth Ann Marrie et al. LANCET NEUROLOGY
- Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis
- (2010) Axel Petzold et al. LANCET NEUROLOGY
- Neurofilament light as a prognostic marker in multiple sclerosis
- (2010) Jonatan Salzer et al. Multiple Sclerosis Journal
- A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
- (2010) C. Collin et al. NEUROLOGICAL RESEARCH
- Brainstem lesions in clinically isolated syndromes
- (2010) M. Tintore et al. NEUROLOGY
- A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
- (2010) Gavin Giovannoni et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preferential recruitment of interferon-γ-expressing TH17 cells in multiple sclerosis
- (2009) Hania Kebir et al. ANNALS OF NEUROLOGY
- Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
- (2009) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis
- (2009) Jan D. Lünemann et al. ANNALS OF NEUROLOGY
- Smoking and Disease Progression in Multiple Sclerosis
- (2009) Brian C. Healy et al. ARCHIVES OF NEUROLOGY
- MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome
- (2009) Jessica M Nielsen et al. BMC Neurology
- CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis
- (2009) J. M. Fletcher et al. JOURNAL OF IMMUNOLOGY
- Clinical predictors of early second event in patients with clinically isolated syndrome
- (2009) Ellen M. Mowry et al. JOURNAL OF NEUROLOGY
- Responsiveness of patient reported outcome measures in multiple sclerosis relapses: the REMS study
- (2009) A Giordano et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Demyelination, Inflammation, and Neurodegeneration in Multiple Sclerosis Deep Gray Matter
- (2009) Marco Vercellino et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Responsiveness of patient-based and external rating scales in multiple sclerosis: Head-to-head comparison in three clinical settings
- (2009) Stefan M. Gold et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial
- (2009) Andrew D Goodman et al. LANCET
- Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study
- (2009) Eva Havrdova et al. LANCET NEUROLOGY
- Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score
- (2009) Philip L De Jager et al. LANCET NEUROLOGY
- CADASIL
- (2009) Hugues Chabriat et al. LANCET NEUROLOGY
- The development of patient-reported outcome indices for multiple sclerosis (PRIMUS)
- (2009) LC Doward et al. Multiple Sclerosis Journal
- Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes
- (2009) Valentina Zipoli et al. Multiple Sclerosis Journal
- Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci
- (2009) Philip L De Jager et al. NATURE GENETICS
- Clinical prognostic factors in multiple sclerosis: a natural history review
- (2009) Alexandra Degenhardt et al. Nature Reviews Neurology
- A reassessment of the plateauing relationship between T2 lesion load and disability in MS
- (2009) M. P. Sormani et al. NEUROLOGY
- Remyelination capacity of the MS brain decreases with disease chronicity
- (2009) T. Goldschmidt et al. NEUROLOGY
- Sleep disorders in patients with multiple sclerosis
- (2009) Steven D. Brass et al. SLEEP MEDICINE REVIEWS
- Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis
- (2008) L. K. Fisniku et al. BRAIN
- Regulatory T cells fail to suppress CD4+ T-bet+T cells in relapsing multiple sclerosis patients
- (2008) Giovanni Frisullo et al. IMMUNOLOGY
- EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2
- (2008) Jan D. Lünemann et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-12– and IL-23–modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition
- (2008) Mark A. Kroenke et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord
- (2008) C P Gilmore et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography
- (2008) F Costello et al. Multiple Sclerosis Journal
- Smoking is a risk factor for early conversion to clinically definite multiple sclerosis
- (2008) F Di Pauli et al. Multiple Sclerosis Journal
- Remyelination in the CNS: from biology to therapy
- (2008) Robin J. M. Franklin et al. NATURE REVIEWS NEUROSCIENCE
- Variants of Multiple Sclerosis
- (2008) Jack H. Simon et al. NEUROIMAGING CLINICS OF NORTH AMERICA
- Temporal trends in the incidence of multiple sclerosis: A systematic review
- (2008) A. Alonso et al. NEUROLOGY
- The Immunology of Multiple Sclerosis
- (2008) Amit Bar-Or SEMINARS IN NEUROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More